T. Ohmura et al., Effects of terfenadine, astemizole and epinastine on electrocardiogram in conscious cynomolgus monkeys, EUR J PHARM, 378(2), 1999, pp. 169-175
We examined the effects of non-sedative histamine H-1 receptor antagonists
on the electrocardiogram (ECG) in conscious cynomolgus monkeys. Terfenadine
(3 mg kg(-1) h(-1), i.v.) and astemizole (0.3 and 1 mg kg(-1) h(-1), i.v.)
caused significant time-dependent increases in the QT interval and QTc Baz
ett (QTc). However, normal ECG forms were found during a 60-min infusion of
epinastine (3 mg kg(-1) h-' i.v.), A higher dose of epinastine (10 mg kg(-
1) h-', i.v.) increased the QTc and PR interval only 5 min after the start
of the infusion. The minimum plasma concentrations of terfenadine, astemizo
le and epinastine which caused QTc prolongation were 85, 35 and over than 3
600 ng/ml, respectively. These drugs did not alter the PQ and QRS intervals
and did not cause arrhythmia or atrioventricular block. Our results are co
nsistent with the clinical observation that prolongation of QTc is caused b
y terfenadine and astemizole but not by epinastine. Thus, measurement of QT
e in cynomolgus monkey appears to be a useful approach for evaluating the p
otential cardiotoxicity of histamine H-1, receptor antagonists. (C) 1999 El
sevier Science B.V. All rights reserved.